ROYALTY PHARMA PLC CLASS A (RPRX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for RPRX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| RPRX | Independent Director | 61 | ["Commissioner, Women’s National Basketball Association","Leadership","Business Strategy","Technology/Cybersecurity","Public Company CEO","FIRST Commissioner of the Women’s National Basketball Association since July 2019","Former CEO of Deloitte from 2014 to 2019","Experience in global business operations, finance, leadership, strategy and risk management","Certified Public Accountant","Audit committee financial expert","financial expert","audit committee experience"] | ["Audit Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| MCD | Commissioner; Women’s National Basketball Association; Chair | 61 | ["Women’s National Basketball Association","Wealth of experience in global business operations","Finance","Leadership","Brand","Customer strategy","Financial reporting","Internal controls","Risk management","Strong leadership and governance experience","Valuable regulatory experience","Certified public accountant","Audit committee financial expert","audit committee financial expert","financially literate"] | ["AFC","Audit & Finance","Corporate Responsibility","Executive","Audit & Finance Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Ms. Engelbert serves as the first Commissioner of the Women s National Basketball Association since July 2019. Previously, Ms. Engelbert was with Deloitte from 1986 through 2019, and held various senior positions, including as a partner serving the pharmaceutical and life sciences practice for over two decades, and then as CEO from 2014 to 2019. Ms. Engelbert previously served on the board of Deloitte and as the first woman chair of the Center for Audit Quality Governing Board. Ms. Engelbert also served as the first woman chair of the Catalyst Board, a global non-profit organization that promotes inclusive workplaces for women. She was a founding member of the CEO Action for Diversity and Inclusion, is a vice chair of the Partnership for New York City, serves on The Business Council, the USGA Executive Committee and previously served as a member of the Business Roundtable, where she sat on the Education & Workforce and Immigration committees. Other Public Company Directorships: McDonald s Corporation (2019-present) Qualifications: Ms. Engelbert was selected to serve on our Board because her experience as Commissioner of a professional sports league and as former chief executive officer of Deloitte LLP provides knowledge of global business operations, finance, leadership, strategy and risk management matters. Having led a firm of 100,000 professionals at Deloitte LLP, she also brings significant experience in talent management. She is a Certified Public Accountant. Ms. Engelbert s qualification as an audit committee financial expert is an important attribute as a member of our Audit Committee.